Clenbuterol (Duke University)

N/A

Report date: 2026/03/20 20:03:07

Base Information

Drug NameClenbuterol (Duke University)
Drug Alias NameATX-04
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-2 adrenergic receptor agonists
TargetsBeta-2 adrenergic receptor
Therapy Area/IndicationsGlycogen Storage Disease Type II
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDuke University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDuke UniversityAvenue Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsGlycogen Storage Disease Type II

Other Information

ATC CodeN/A
Related LinksN/A